首页|期刊导航|中山大学学报(医学科学版)|麻醉药物与围术期管理影响肿瘤转归:从机制到临床的探索

麻醉药物与围术期管理影响肿瘤转归:从机制到临床的探索OA

Anesthetic Agents and Perioperative Management in Tumor Outcomes:from Mechanisms to Clinical Exploration

中文摘要英文摘要

围术期管理,特别是麻醉方案的选择与实施,正日益被视为影响肿瘤患者术后长期转归的潜在可调控因素.本文系统探讨了围术期影响肿瘤转归的关键病理生理机制,包括手术创伤引发的炎症与免疫抑制、生理应激反应以及由此导致的肿瘤微环境改变,为肿瘤细胞逃逸和进展创造了契机.核心聚焦于不同类别麻醉药物(镇静催眠药、吸入麻醉药、局麻药、镇痛药)对肿瘤生物学行为(如增殖、侵袭、转移、免疫应答)的潜在影响及其可能的分子机制.同时,本文综述了当前关于麻醉方式选择及具体麻醉管理策略对肿瘤患者预后影响的临床研究证据.尽管现有临床证据尚不足以确立能明确改善肿瘤预后的标准化围术期麻醉方案,但基础与临床研究均强烈提示,优化围术期管理(涵盖麻醉药物选择、麻醉技术应用及综合支持措施)具有通过多维度调控应激-炎症-免疫轴及肿瘤微环境,进而影响肿瘤转归的潜力.未来研究需致力于深入阐明相关机制,开展高质量的前瞻性临床试验,以推动基于循证医学的、精准化和个体化的肿瘤患者围术期管理策略的构建,最终改善患者长期生存.

Perioperative management,especially the selection and implementation of anesthesia protocols,is increasingly regarded as a potentially modifiable factor affecting long-term postoperative outcomes in tumor patients.This paper systematically discusses the key pathophysiological mechanisms in the perioperative period that influence tumor outcomes,including inflammation and immunosuppression caused by surgical trauma,physiological stress responses,and subsequent changes in the tumor microenvironment,which create opportunities for tumor cell escape and progression.It focuses on the potential effects of different types of anesthetics(sedative-hypnotics,inhaled anesthetics,local anesthetics,analgesics)on the biological behaviors of tumors(such as proliferation,invasion,metastasis,and immune response)as well as their possible molecular mechanisms.Meanwhile,this paper reviews current clinical research evidence on the impact of anesthesia modality selection and specific anesthesia management strategies on the prognosis of tumor patients.Although existing clinical evidence is insufficient to establish standardized perioperative anesthesia protocols that can significantly improve tumor prognosis,both basic and clinical studies strongly suggest that optimizing perioperative management(including the selection of anesthetics,the application of anesthesia techniques,and comprehensive supportive measures)has the potential to influence tumor outcomes by multi-dimensionally regulating the stress-inflammation-immune axis and the tumor microenvironment.Future research should focus on further clarifying the relevant mechanisms and conducting high-quality prospective clinical trials,so as to promote the establishment of evidence-based,precise and individualized perioperative management strategies for tumor patients,and ultimately improve long-term patient survival.

张楚逸;靳三庆

中山大学附属第六医院麻醉科,广东 广州 510655||广州市黄埔区中六生物医学创新研究院,广东 广州 510005中山大学附属第六医院麻醉科,广东 广州 510655||广州市黄埔区中六生物医学创新研究院,广东 广州 510005

医药卫生

围术期管理麻醉药物应激调控免疫重塑肿瘤转归免疫抑制临床证据精准医疗

perioperative managementanesthetic drugsstress modulationimmune remodelingoncologic outcomesimmunosuppressionclinical evidenceprecision medicine

《中山大学学报(医学科学版)》 2026 (4)

583-593,11

广东省医学会临床研究基金会(2024HY-B4002)

10.11714/jsysu.med.YX20260017

评论